Prescription trends on the preference of antibiotics for the management of respiratory tract infections in India

M. S, Krishna Kumar M
{"title":"Prescription trends on the preference of antibiotics for the management of respiratory tract infections in India","authors":"M. S, Krishna Kumar M","doi":"10.22271/27069567.2024.v6.i2a.546","DOIUrl":null,"url":null,"abstract":"Background: Respiratory tract infections are a major cause of morbidity and mortality in developing countries. Irrational prescribing of various drugs for respiratory diseases are common practice worldwide. Considering this scenario, the present study was undertaken to analyse recent prescribing trends in the management of Respiratory Tract Infections (RTIs). Methodology: This study collected data from a multiple-response questionnaire-based survey among 442 clinicians via email or an online survey platform. The questionnaire focused on the prevalence, symptoms, causes, clinical characteristics, management of RTI, and the usage of respiratory medications in clinical practice. Results: About 47% of respondents said that 11-30% of their patients need more than one antibiotic for RTI. 53% of respondents observed pharyngitis/ tonsillitis as the most common indication of RTI. Close to half of the respondents (45%) prescribe antibiotics to 50-75% of their patients. Nearly half of the respondents (48%) said that cefpodoxime was the most common antibiotic they prescribe regularly in their practice. 37% of respondents prefer cefpodoxime in bacterial tonsillopharyngitis while 21% prefer amoxicillin + clavulanic acid and azithromycin. 44% of respondents prefer cefpodoxime in AECB (acute bacterial exacerbation of chronic bronchitis) while 15% prefer amoxicillin + clavulanic acid and only 10% prefer azithromycin. 51% of respondents prefer cefpodoxime in bacterial rhino sinusitis (acute bacterial exacerbation of chronic bronchitis). Conclusion: The prescribing patterns for the management of RTIs in the clinical practice were inconsistent with current guidelines. Strict adherence to guidelines must be ensured and antibiotic prescribing for RTIs should be discouraged.","PeriodicalId":13835,"journal":{"name":"International Journal of Advanced Research in Medicine","volume":"179 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Advanced Research in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22271/27069567.2024.v6.i2a.546","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Respiratory tract infections are a major cause of morbidity and mortality in developing countries. Irrational prescribing of various drugs for respiratory diseases are common practice worldwide. Considering this scenario, the present study was undertaken to analyse recent prescribing trends in the management of Respiratory Tract Infections (RTIs). Methodology: This study collected data from a multiple-response questionnaire-based survey among 442 clinicians via email or an online survey platform. The questionnaire focused on the prevalence, symptoms, causes, clinical characteristics, management of RTI, and the usage of respiratory medications in clinical practice. Results: About 47% of respondents said that 11-30% of their patients need more than one antibiotic for RTI. 53% of respondents observed pharyngitis/ tonsillitis as the most common indication of RTI. Close to half of the respondents (45%) prescribe antibiotics to 50-75% of their patients. Nearly half of the respondents (48%) said that cefpodoxime was the most common antibiotic they prescribe regularly in their practice. 37% of respondents prefer cefpodoxime in bacterial tonsillopharyngitis while 21% prefer amoxicillin + clavulanic acid and azithromycin. 44% of respondents prefer cefpodoxime in AECB (acute bacterial exacerbation of chronic bronchitis) while 15% prefer amoxicillin + clavulanic acid and only 10% prefer azithromycin. 51% of respondents prefer cefpodoxime in bacterial rhino sinusitis (acute bacterial exacerbation of chronic bronchitis). Conclusion: The prescribing patterns for the management of RTIs in the clinical practice were inconsistent with current guidelines. Strict adherence to guidelines must be ensured and antibiotic prescribing for RTIs should be discouraged.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度治疗呼吸道感染首选抗生素的处方趋势
背景:呼吸道感染是发展中国家发病和死亡的主要原因。不合理地开具各种治疗呼吸道疾病的处方是全世界的普遍做法。有鉴于此,本研究旨在分析近期治疗呼吸道感染(RTI)的处方趋势。研究方法:本研究通过电子邮件或在线调查平台对 442 名临床医生进行了多应答问卷调查,收集了相关数据。问卷主要涉及 RTI 的发病率、症状、病因、临床特征、管理方法以及临床实践中呼吸道药物的使用情况。结果显示约 47% 的受访者表示,11%-30% 的患者需要使用一种以上的抗生素治疗 RTI。53%的受访者认为咽炎/扁桃体炎是最常见的 RTI 指征。近一半的受访者(45%)为 50-75% 的患者开具抗生素处方。近一半的受访者(48%)表示,头孢泊肟是他们经常处方的最常用抗生素。37% 的受访者首选头孢泊肟治疗细菌性扁桃体咽炎,21% 的受访者首选阿莫西林+克拉维酸和阿奇霉素。44%的受访者首选头孢泊肟治疗 AECB(慢性支气管炎急性细菌性恶化),15%的受访者首选阿莫西林+克拉维酸,只有 10%的受访者首选阿奇霉素。对于细菌性鼻窦炎(慢性支气管炎急性细菌性加重),51% 的受访者首选头孢泊肟。结论临床实践中治疗 RTI 的处方模式与现行指南不一致。必须确保严格遵守指南,不鼓励为 RTIs 开具抗生素处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Detection of MRSA and MSSA biofilms in clinical specimens from a tertiary care hospital located in Hyderabad Bone cutter, gomco clamp, and plastibell device for circumcision in neonates and infants: A comprehensive review Comparative analysis of copper and zinc levels and their association with cardiac indicators in chronic heart patients in Maysan governorate A study on the new onset of diabetes mellitus in patients with dengue fever The role of musculoskeletal ultrasound in predicting treatment plan in rheumatoid arthritis patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1